Literature DB >> 26972879

Medicinal plants used to treat TB in Ghana.

Joseph Mwanzia Nguta1, Regina Appiah-Opong2, Alexander K Nyarko2, Dorothy Yeboah-Manu3, Phyllis G A Addo4.   

Abstract

AIMS: The current study was designed to document medicinal plant species that are traditionally used to treat tuberculosis (TB) by Ghanaian communities.
METHODS: The medicinal plants used against TB or its signs and symptoms were selected using library and online published data searches. A guided questionnaire interview was also conducted with a botanist involved in plant collection at the Centre for Scientific Research into Plant Medicine (CSRPM) at Mampong. Data obtained were entered in Excel and summarized into means and frequencies using SPSS 12.0.1 for windows, and expressed as tables and bar graphs.
RESULTS: A total of 15 medicinal plant species distributed between 13 genera and 13 families were documented. The following medicinal plant species were found to be used against TB in Greater Accra and Eastern parts of Ghana: Azadirachta indica A. Juss. Stem bark (Meliaceae), Hygrophila auriculata Heine, whole plant (Acanthaceae), Chenopodium ambrosioides L. leaves (Amaranthaceae), Coix lacryma-jobi L. glumes (Poaceae), Solanum torvum Sw. unripe fruits (Solanaceae), Solanum torvum Sw. leaves (Solanaceae), Bidens pilosa L. whole plant (Asteraceae), Phyllanthus fraternus G.L. Webster leaves (Phyllanthaceae), Dissotis rotundifolia (Sm.) Triana, leaves (Melastomataceae), Cymbopogon giganteus Chiov. Leaves (Poaceae), Cyperus articulatus L. roots (Cyperaceae), Allium sativum L. bulb (Amaryllidaceae), Zingiber officinale Roscoe, rhizomes (Zingiberaceae), Allium cepa L. bulbs (Amaryllidaceae), Allium cepa L. leaves (Amaryllidaceae), Aloe vera var. barbadensis aqueous extract from leaves (Xanthorrhoeaceae), Aloe vera var. barbadensis organic extract from leaves (Xanthorrhoeaceae), Cocos nucifera Linn, water (Arecaceae) and Cocos nucifera Linn. Husk (Arecaceae).
CONCLUSIONS: The collected plant species could be a source of a new class of drugs against TB. Bioactivity guided fractionation is recommended to identify lead compounds for antimycobacterial activity. The current paper documents for the first time medicinal plant species used by Ghanaian communities to treat TB. These results are a basis for selection of plants for further pharmacological, toxicological and phytochemical studies in developing new plant-based antimycobacterial drugs.
Copyright © 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ghana; Medicinal plants; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26972879     DOI: 10.1016/j.ijmyco.2015.02.003

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  14 in total

Review 1.  A review on the potential of underutilized Blackjack (Biden Pilosa) naturally occurring in sub-Saharan Africa.

Authors:  Deodata V Mtenga; Asha S Ripanda
Journal:  Heliyon       Date:  2022-05-29

Review 2.  Ethnobotany, ethnopharmacology, and phytochemistry of traditional medicinal plants used in the management of symptoms of tuberculosis in East Africa: a systematic review.

Authors:  Samuel Baker Obakiro; Ambrose Kiprop; Isaac Kowino; Elizabeth Kigondu; Mark Peter Odero; Timothy Omara; Lydia Bunalema
Journal:  Trop Med Health       Date:  2020-08-14

3.  Antimycobacterial and cytotoxic activity of selected medicinal plant extracts.

Authors:  Joseph M Nguta; Regina Appiah-Opong; Alexander K Nyarko; Dorothy Yeboah-Manu; Phyllis G A Addo; Isaac Otchere; Abena Kissi-Twum
Journal:  J Ethnopharmacol       Date:  2016-02-11       Impact factor: 4.360

4.  Evaluation of in vivo antimycobacterial activity of some folklore medicinal plants and enumeration of colony forming unit in murine model.

Authors:  Acheenta Gohain Barua; Himangshu Raj; Pranab Konch; P Hussain; Chandana C Barua
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

5.  Cyperus articulatus L. (Cyperaceae) Rhizome Essential Oil Causes Cell Cycle Arrest in the G2/M Phase and Cell Death in HepG2 Cells and Inhibits the Development of Tumors in a Xenograft Model.

Authors:  Mateus L Nogueira; Emilly J S P de Lima; Asenate A X Adrião; Sheila S Fontes; Valdenizia R Silva; Luciano de S Santos; Milena B P Soares; Rosane B Dias; Clarissa A Gurgel Rocha; Emmanoel V Costa; Felipe M A da Silva; Marcos A Vannier-Santos; Nállarett M D Cardozo; Hector H F Koolen; Daniel P Bezerra
Journal:  Molecules       Date:  2020-06-09       Impact factor: 4.411

6.  Ethno-medicinal documentation of polyherbal medicines used for the treatment of tuberculosis in Amathole District Municipality of the Eastern Cape Province, South Africa.

Authors:  Elizabeth Bosede Famewo; Anna Maria Clarke; Anthony Jide Afolayan
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

7.  Antimycobacterial Activity and Safety Profile Assessment of Alpinia galanga and Tinospora cordifolia.

Authors:  Mohamed F Alajmi; Ramzi A Mothana; Adnan J Al-Rehaily; Jamal M Khaled
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-08       Impact factor: 2.629

8.  Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity.

Authors:  Apurba Sarkar; Shreya Ghosh; Rahul Shaw; Madhu Manti Patra; Fatema Calcuttawala; Noyonika Mukherjee; Sujoy K Das Gupta
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

9.  In vitro antimycobacterial and cytotoxic data on medicinal plants used to treat tuberculosis.

Authors:  Joseph M Nguta; Regina Appiah-Opong; Alexander K Nyarko; Dorothy Yeboah-Manu; Phyllis G A Addo; Isaac D Otchere; Abena Kissi-Twum
Journal:  Data Brief       Date:  2016-04-01

10.  Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana.

Authors:  Patrick Amoateng; Emmanuel Quansah; Thomas K Karikari; Alex Asase; Dorcas Osei-Safo; Kennedy Kwami Edem Kukuia; Isaac Kingsley Amponsah; Alexander K Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.